Waverly Advisors LLC Increases Position in MetLife, Inc. $MET

Posted by on Jul 29th, 2026

Waverly Advisors LLC grew its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 33.6% in the 1st quarter, Holdings Channel.com reports. The firm owned 65,971 shares of the financial services provider’s stock after acquiring an additional 16,582 shares during the period. Waverly Advisors LLC’s holdings in MetLife were worth $4,665,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in the stock. Entropy Technologies LP raised its stake in MetLife by 157.6% during the first quarter. Entropy Technologies LP now owns 192,996 shares of the financial services provider’s stock valued at $13,649,000 after buying an additional 118,064 shares during the last quarter. TCM Advisors LLC grew its stake in shares of MetLife by 9.5% in the first quarter. TCM Advisors LLC now owns 10,400 shares of the financial services provider’s stock worth $735,000 after acquiring an additional 900 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund increased its holdings in shares of MetLife by 118.9% during the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 183,585 shares of the financial services provider’s stock valued at $12,983,000 after acquiring an additional 99,706 shares in the last quarter. Public Employees Retirement System of Ohio increased its holdings in shares of MetLife by 0.7% during the first quarter. Public Employees Retirement System of Ohio now owns 274,598 shares of the financial services provider’s stock valued at $19,420,000 after acquiring an additional 1,935 shares in the last quarter. Finally, FCA Corp TX raised its position in shares of MetLife by 2.3% in the 1st quarter. FCA Corp TX now owns 29,582 shares of the financial services provider’s stock worth $2,092,000 after purchasing an additional 655 shares during the last quarter. 94.99% of the stock is owned by institutional investors.

MetLife Trading Up 2.6%

NYSE:MET opened at $97.65 on Wednesday. The company has a current ratio of 0.20, a quick ratio of 0.20 and a debt-to-equity ratio of 0.53. MetLife, Inc. has a 12 month low of $67.33 and a 12 month high of $97.69. The company has a market cap of $62.83 billion, a PE ratio of 18.92, a price-to-earnings-growth ratio of 0.73 and a beta of 0.78. The company has a 50 day simple moving average of $87.88 and a two-hundred day simple moving average of $79.77.

MetLife (NYSE:MET – Get Free Report) last released its quarterly earnings results on Wednesday, May 6th. The financial services provider reported $2.42 earnings per share for the quarter, beating the consensus estimate of $2.27 by $0.15. The firm had revenue of $14.18 billion for the quarter, compared to analysts’ expectations of $19.49 billion. MetLife had a return on equity of 22.60% and a net margin of 4.66%.The company’s revenue was up 2.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.96 EPS. Research analysts forecast that MetLife, Inc. will post 9.89 earnings per share for the current year.

MetLife Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 8th. Shareholders of record on Tuesday, August 4th will be issued a $0.5925 dividend. The ex-dividend date of this dividend is Tuesday, August 4th. This represents a $2.37 dividend on an annualized basis and a yield of 2.4%. MetLife’s dividend payout ratio is currently 45.93%.

Analyst Upgrades and Downgrades

MET has been the subject of several recent analyst reports. Wall Street Zen cut shares of MetLife from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. Bank of America reduced their price target on shares of MetLife from $103.00 to $99.00 and set a “buy” rating for the company in a research report on Tuesday, April 14th. UBS Group boosted their price objective on shares of MetLife from $102.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 8th. Mizuho lifted their target price on MetLife from $95.00 to $102.00 and gave the stock an “outperform” rating in a report on Thursday, July 9th. Finally, Jefferies Financial Group upped their price target on MetLife from $97.00 to $103.00 and gave the company a “buy” rating in a report on Friday, July 10th. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and two have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $100.50.

View Our Latest Analysis on MetLife

MetLife Profile

(Free Report)

MetLife, Inc is a global provider of insurance, annuities and employee benefit programs. Headquartered in New York City, the company offers a range of risk protection and retirement solutions to individuals, employers and institutional clients. Its core businesses include life insurance, group benefits, retirement products such as annuities, and supplemental health products including dental and disability coverage.

In addition to traditional life and group insurance, MetLife provides workplace benefits and voluntary products distributed through employer-sponsored programs.

Featured Articles

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.